B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ADRB1

MOLECULAR TARGET

adrenoceptor beta 1

UniProt: P08588NCBI Gene: 15344 compounds

ADRB1 (adrenoceptor beta 1) is targeted by 44 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ADRB1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Propranolol3.7140
2Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on3.6437
3Atenolol2.9418
4Alprenolol2.5612
5Norepinephrine Precursor of epinephrine that is secreted by2.5612
6Practolol2.4811
7Timolol2.4811
8Pindolol2.4010
9Epinephrine2.309
10Sotalol2.309
11Acebutolol1.795
12Bisoprolol1.795
13Bupranolol1.795
14Xamoterol1.795
15Bunolol1.614
16Carteolol1.614
17Carvedilol1.614
18Levalbuterol1.393
19Levalbuterol1.393
20Celiprolol1.393
21Quipazine1.393
22Fenoterol1.102
23Labetalol1.102
24Lysergic Acid Diethylamide Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is1.102
25Nadolol1.102
26Prenalterol1.102
27Sertraline0.691
28Aripiprazole0.691
29Benzethonium Bactericidal cationic quaternary ammonium surfactant used as0.691
30Bromocriptine0.691
31Chlorhexidine0.691
32cinacalcet0.691
33Clenbuterol0.691
34Codeine0.691
35Lisuride0.691
36Methylergonovine0.691
37Nebivolol0.691
38Noscapine0.691
39Nylidrin0.691
40Oxprenolol0.691
41Phenylephrine0.691
42Ranolazine0.691
43Tamsulosin0.691
44Tetrahydropapaveroline0.691

About ADRB1 as a Drug Target

ADRB1 (adrenoceptor beta 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 44 compounds with documented ADRB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ADRB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.